Donald West and Mary Elizabeth King Professor and Chair
Department of Pathology and the College
Daniel A. Arber is an internationally recognized hematopathologist, researcher, and educator, and an authority on the diagnosis and classification of acute myeloid leukemia. His research focuses on molecular genetic and immunophenotypic changes in blood cancers. He recently presented proposed changes to the 2016 World Health Organization (WHO) classification of myelodysplastic syndromes, including the incorporation of genetic changes, and was the lead author of a summary of the 2016 WHO classification of myeloid neoplasms and acute leukemias published earlier this year in Blood. He co-chaired a group of leading hematopathologists and hematologists who developed joint College of American Pathology/American Society of Hematology guidelines for the initial workup for acute leukemia, which was presented as a spotlight session at an American Society of Hematology meeting and published in 2017.
Arber is the author of more than 250 publications, book sections, and chapters, and has edited a number of textbooks in the field. He received Stanford University School of Medicine Teaching Excellence Awards, as well as the Stanford University Medical Center Department of Pathology Clinical Pathology Senior Faculty Teaching Award.
He received his MD from the University of Texas. Most recently, he was the Ronald F. Dorfman Professor in Pathology, vice chair for clinical services, senior associate chair for hematopathology, and medical director of anatomic pathology and clinical laboratory services at Stanford University.